 Pfizer Inc. PFE, -0.51 and German partner BioNTech SE BNTX, 0.26 on Tuesday announced updated COVID vaccine data supporting efficacy in children aged 6 months through 4 years of age. The companies said updated analysis from 34 cases occurring at least seven days after a three-dose regimen showed 73.2 vaccine efficacy among children in that age group. 